Relay Therapeutics, Inc. Common Stock

RLAYNASDAQUSD
12.94 USD
0.40 (3.15%)🟢LIVE (AS OF 11:22 AM EDT)
🟢Market: OPEN
Open?$12.63
High?$13.34
Low?$12.48
Prev. Close?$12.54
Volume?1.0M
Avg. Volume?2.8M
VWAP?$13.03
Rel. Volume?0.38x
Bid / Ask
Bid?$12.91 × 100
Ask?$12.97 × 100
Spread?$0.06
Midpoint?$12.94
Valuation & Ratios
Market Cap?2.2B
Shares Out?178.7M
Float?103.0M
Float %?59.4%
P/E Ratio?N/A
P/B Ratio?3.95
EPS?-$1.55
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?22.61Strong
Quick Ratio?22.61Strong
Cash Ratio?3.28Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
58/100
P/E?
N/A
P/B?
3.95FAIR
P/S?
145.95HIGH
P/FCF?
N/A
EV/EBITDA?
-7.2CHEAP
EV/Sales?
140.48HIGH
Returns & Efficiency
ROE?
-48.8%WEAK
ROA?
-44.5%WEAK
Cash Flow & Enterprise
FCF?$-235865000
Enterprise Value?$2.2B
Related Companies
Loading...
News
Profile
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Employees
192
Market Cap
2.2B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2020-07-16
Address
60 HAMPSHIRE STREET
CAMBRIDGE, MA 02139
Phone: 617-370-8837